Elevance Health, Inc. ELV
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Elevance Health, Inc. is a U.S.-based health benefits and healthcare services company operating primarily in the managed healthcare, health insurance, and healthcare technology sectors. Formerly known as Anthem, Inc., the company rebranded to Elevance Health in 2022 to reflect a broader healthcare platform strategy extending beyond traditional insurance coverage. The company provides medical, pharmacy, dental, behavioral health, vision, and care management services to individuals, employers, government agencies, and healthcare providers. Its core revenue drivers are commercial health insurance plans, Medicare Advantage products, Medicaid managed care contracts, pharmacy benefit services, and healthcare services delivered through affiliated platforms.
The company serves a broad customer base across commercial employer-sponsored plans, individual Affordable Care Act marketplaces, Medicare beneficiaries, and Medicaid recipients. Elevance Health is one of the largest Blue Cross Blue Shield-affiliated organizations in the United States and operates Blue-branded plans in multiple states through licenses from the Blue Cross Blue Shield Association. Its strategic positioning is supported by large-scale membership, extensive provider networks, integrated pharmacy and care delivery capabilities, and significant participation in government-sponsored healthcare programs. The company traces its origins to predecessor Blue Cross organizations established in the 1940s and expanded substantially through mergers and acquisitions before adopting the Elevance Health identity.
Business Operations
Elevance Health organizes its operations through several primary business platforms, including Health Benefits, Carelon, and related healthcare services businesses. The Health Benefits segment includes commercial insurance, Medicare, Medicaid, and Federal Employee Program offerings. Revenue is primarily generated through insurance premiums, government program reimbursements, administrative service fees, and related healthcare products. The company maintains a substantial presence in government-sponsored healthcare, particularly Medicaid managed care and Medicare Advantage, which have become increasingly important growth drivers.
The company’s Carelon platform delivers pharmacy benefit management, behavioral health services, care delivery, analytics, and healthcare enablement services. Through subsidiaries such as CarelonRx, Elevance Health manages pharmacy services and specialty drug programs. The company operates across domestic markets throughout the United States and supports healthcare delivery through provider partnerships, digital health tools, and data analytics capabilities. Elevance Health also maintains relationships with hospitals, physician groups, pharmacies, and employer clients, while leveraging technology investments to coordinate care and manage healthcare costs.
Strategic Position & Investments
Elevance Health’s strategic direction emphasizes integrated healthcare delivery, expansion in government-sponsored programs, digital healthcare services, and value-based care models. The company has invested heavily in healthcare services infrastructure through the development and expansion of Carelon, positioning the platform as a diversified healthcare services business beyond insurance underwriting. Growth initiatives include expanding Medicare Advantage enrollment, increasing Medicaid contract participation, improving behavioral health access, and strengthening pharmacy and home-based care capabilities.
The company has completed multiple acquisitions and strategic investments to broaden its healthcare services portfolio. Notable transactions include the acquisition of BioPlus, a specialty pharmacy business integrated into CarelonRx, and investments supporting digital care coordination and analytics capabilities. Elevance Health has also pursued partnerships with healthcare providers and technology organizations to improve patient outcomes and operational efficiency. Public filings and investor disclosures indicate continued focus on integrated care, AI-enabled healthcare management tools, and long-term cost management initiatives tied to value-based reimbursement models.
Geographic Footprint
Elevance Health is headquartered in Indianapolis, Indiana, and operates primarily throughout the United States. The company maintains Blue Cross Blue Shield-affiliated health plan operations across numerous states, including significant market positions in regions such as the Midwest, South, West, and Mid-Atlantic. Its commercial and government-sponsored healthcare offerings collectively serve tens of millions of medical members nationwide.
Although Elevance Health’s direct operations are concentrated domestically, the company maintains broader operational influence through technology services, pharmacy networks, and healthcare partnerships that support multinational employers and healthcare supply relationships. Its healthcare services and pharmacy operations extend across national provider and pharmaceutical networks, giving the company broad operational reach within the U.S. healthcare ecosystem.
Leadership & Governance
Elevance Health operates under a corporate governance framework led by a board of directors and executive leadership team focused on healthcare affordability, integrated care delivery, and long-term shareholder value. The company’s leadership strategy emphasizes whole-health coordination, digital transformation, and expansion of healthcare services capabilities alongside traditional insurance operations. The company’s transition from Anthem to Elevance Health reflected leadership’s stated objective of evolving into a broader health platform organization.
Key executives include:
- Gail K. Boudreaux – President and Chief Executive Officer
- Mark Kaye – Chief Financial Officer
- Felicia Norwood – Executive Vice President and President, Government Health Benefits
- Morgan Kendrick – Executive Vice President and President, Commercial and Specialty Business Division
- Peter D. Haytaian – Executive Vice President and President, Carelon and CarelonRx
- Rajeev Ronanki – President, Digital Platforms
Information in this overview is based on publicly available disclosures including SEC filings, annual reports, investor presentations, and major financial and industry reporting sources.